# Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome

> **NCT00822679** · PHASE4 · COMPLETED · sponsor: **University of Arizona** · enrollment: 5 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Sleep Disorder

## Interventions

- **DRUG:** Eszopiclone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00822679
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-08
- **Final completion:** 2010-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822679, "Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00822679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*